[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Views 85
Citations 0
In This Issue of JAMA Otolaryngology
November 2014


JAMA Otolaryngol Head Neck Surg. 2014;140(11):993. doi:10.1001/jamaoto.2013.4320

The increase in aging patients with more complicated medical histories and procedures makes it important to evaluate chemoprevention of venous thromboembolism (VTE). Bahl and colleagues spearheaded a retrospective cohort study of 3498 patients admitted for otolaryngologic surgery between September 1, 2003, and June 30, 2010. Patients were stratified into 2 groups based on receipt of VTE prophylaxis; measured outcomes were thromboembolic complications or bleeding within 30 days. There was no significant difference in VTE development between the groups except for those patients with free tissue transfer. Bleeding complications were associated with concomitant use of antiplatelet medications and chemoprophylaxis.